Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-11-05 00:00:00 ET · period of report 2025-10-31 · accession 0001810701-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-05 | 2025-10-31 | BBNX | Palasis Maria | Dir | S - Sale | $26.91 | -1,406 | 9,841 | -13% | -$37.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-31 | S | D | 1,287 | $26.86 | 9,960 | D | — | — | (F2) The weighted average sale price for the transaction reported was $26.8588 and the range of prices were between $26.27 and $27.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-10-31 | S | D | 119 | $27.45 | 9,841 | D | — | — | (F3) The weighted average sale price for the transaction reported was $27.4502 and the range of prices were between $27.32 and $27.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |